Summary: In this article, Catalent's George Buchman was asked to respond and give insight into trends across cell and gene therapy and what we can expect to witness this year.

Summary: In this article, Catalent expert, Victor Vinci was asked to respond and give his insight into manufacturing platforms and how they will help drugmakers meet demands.

Summary: In this article, Catalent expert George Buchman discusses the recent increase in gene therapy approvals & how we can accelerate the manufacturing speed with platform processes.

In this article, find out how GPEx® cell line and pools can accelerate the timelines to First-in-human studies.

A poster presentation of how Catalent's GPEx® Lightning system enables faster development timelines, robust manufacturing processes, improved titers, and higher final yields.

Summary: Learn how Catalent’s formulation development and integrated manufacturing services can help EBPs through the complexities of the drug development process.

Watch this webinar to learn how Quality by Design (QbD) transforms biologics manufacturing by focusing on process understanding and design control.

In this episode of “The Top Line”, Fierce Pharma’s Fraiser Kansteiner interviews Delara Motlagh, head of cell therapy at Catalent; Becky Butler Cap, senior vice president of biotherapies at Vitalant; and Kevin Kyle, CEO of Germfree. The conversation covers cell collection, the critical first step in advanced therapy manufacturing.

Summary: In this ebook, access expert insight into analytical approaches for traditional biologics, including advanced therapies.

Summary: Catalent Biologics provides comprehensive services to meet complex biologic development needs. Click to see our global locations and services...